• FOLLOW US
Video Player
  • Email
  • share

Biotechs and banks lead S&P 500 to milestone

Summary: Equities were in favor, thanks to deals between drug maker Roche and biotech company InterMune along with plans of a hook up between Burger King and Tim Hortons, leading the S&P to break above 2,000 for the first time. Conway G. Gitten

http://www.digtriad.com/video/3748550317001/49924258001/Biotechs-and-banks-lead-SampP-500-to-milestone http://cdn.newslook.com/81/813760612b7110fece21af5a64b39ac6/images/frame_ext.jpg Biotechs and banks lead S&P 500 to milestone Summary: Equities were in favor, thanks to deals between drug maker Roche and biotech company InterMune along with plans of a hook up between Burger King and Tim Hortons, leading the S&P to break above 2,000 for the first time. Conway G. Gitten FinanceCelgeneEuropeUnited Kingdomscienceconway g. gittensCanadavertexnewslookSNPXXswitzerlandUnited States of AmericafranceWorldS & P Syndicate Public Company Limited 02:18

Next Up

    

More Videos